Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program (NASDAQ:ABSI)March 25, 2026
Share Facebook Twitter LinkedIn Pinterest Email Meta found guilty by N.M. jury in child safety trial; receives $375M penalty
Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program (NASDAQ:ABSI)March 25, 2026